M&A is where bankers test whether you understand how a deal actually gets done. The mechanics — merger model, accretion/dilution, financing mix — are testable in fifteen minutes. The harder layer is judgment: which synergies are real, why the buyer is paying this premium, what the financing mix says about the strategy, and whether the EPS impact is the right metric to lean on.
This guide covers the M&A questions you will actually be asked, with the structured answers we drill candidates on inside Banking Prep AI.
Why bankers ask M&A questions
M&A questions test three things at once: technical mechanics (can you build a merger model under pressure), commercial intuition (can you defend why a buyer would pay this price), and judgment (do you know when to push back on a CEO who is over-paying). Even product-group analysts in DCM or ECM are expected to have a working M&A vocabulary, because most deal teams cross product lines.
Expect a layered question structure: walk-through, then accretion/dilution math, then a what-if. The interviewer rarely cares about the exact number — they care about whether your model output is directionally right and whether you can explain why it moves when an assumption changes.
The merger model in five steps
The model is mechanical, but each step has its own follow-up trap. Memorize the sequence and the why behind each adjustment.
- 1. Standalone projections. Three years of acquirer and target P&L, taken from public filings or management projections. Match accounting standard, fiscal year-ends, and currency before combining anything.
- 2. Deal structure. Purchase price (equity value + assumed debt = enterprise value), consideration mix, transaction fees (1–3% of equity value), refinanced debt and breakup costs. State whether goodwill or step-up applies.
- 3. Pro forma adjustments. New interest on acquisition debt, foregone interest on cash used (after-tax), new shares issued, intangibles amortization from PPA, synergies (phased in years 1–3), one-time deal/integration costs.
- 4. Combine and tax. Sum operating lines, then apply pro forma tax rate. Synergies and integration costs are after-tax. Watch for jurisdictional mix if the deal crosses borders.
- 5. EPS calculation. Pro forma net income / pro forma diluted shares (basic + new shares issued + treasury method on options). Compare to standalone acquirer EPS for accretion/dilution.
Accretion / dilution math
The single most-asked technical in M&A. The quick framework: a deal is accretive when the after-tax earnings yield of what you buy exceeds the after-tax cost of how you finance it.
For a cash-financed deal: accretive if target after-tax earnings yield (target NI / equity purchase price) > acquirer after-tax cost of cash or new debt. For a stock-financed deal: accretive if acquirer P/E > target P/E (equivalently, the target's earnings yield exceeds the acquirer's earnings yield).
Cash deal: Accretive if Target EPS / Cash-Per-Share Paid > After-Tax Cost of Cash Stock deal: Accretive if Acquirer P/E > Target P/E Mixed deal: Weighted average of the two thresholds, by funding share.
Synergies: framing, sizing, defending
Synergies are how acquirers justify premiums. There are two flavors. Cost synergies — headcount overlap, facility consolidation, procurement scale, IT and back-office — are higher confidence and tend to materialize within 12–24 months. Revenue synergies — cross-sell, distribution access, bundling, pricing — are lower confidence and capture rates rarely exceed 50% of management estimates.
Quantify cost synergies as a percentage of combined opex (typical: 3–8% in same-industry deals, less in conglomerate deals). Tax-affect them, discount as a perpetuity at the combined WACC, and net out one-time integration costs (typically 1–2x annual run-rate synergies, taken as a charge in years one and two).
Consideration mix and financing
The mix of cash, stock, and assumed debt is a strategic choice, not just a financing one. Cash signals confidence and avoids dilution but consumes liquidity and may require new debt. Stock shares deal risk with target shareholders (they get acquirer shares, so synergies have to materialize for them too), but dilutes the acquirer and locks in an exchange ratio that floats with share price between signing and closing.
All-cash deals are typically more accretive when interest rates are low and the acquirer has cash or unused debt capacity. All-stock deals are typically more accretive when the acquirer's P/E is much higher than the target's. Mixed deals are most common — they balance dilution, leverage, and signaling.
| Mix | Best when | Watch out for |
|---|---|---|
| All cash | Acquirer has excess cash or cheap debt; high confidence in the deal | Liquidity strain; covenant pressure post-close |
| All stock | Acquirer P/E significantly higher than target's; want to share risk | Dilution; share price drop between signing and closing changes deal value |
| Cash + stock | Balance dilution and leverage; satisfy diverse target shareholders | Complexity; tax treatment differs by component for target shareholders |
| Cash + assumed debt | Capital-intensive target with stable cash flows | Refinancing risk; combined leverage may breach covenants |
Purchase price allocation (PPA)
Under acquisition accounting, the purchase price is allocated to identifiable assets and liabilities at fair value. The excess over net identifiable fair value becomes goodwill. Identifiable intangibles — customer relationships, technology, trade names, in-process R&D — are amortized over useful life, creating non-cash expense that hits pro forma EPS. Goodwill is not amortized but tested for impairment annually.
PPA matters in interviews because intangible amortization is a real EPS drag that candidates routinely forget. A deal that looks accretive before PPA can flip to dilutive once amortization is added. The fix is not to ignore amortization but to disclose two EPS numbers — GAAP (post-PPA) and adjusted (pre-PPA) — and let the audience pick.
Asset vs stock deal
Stock deal: buyer acquires the legal entity and inherits all assets, liabilities, contracts, and tax history. NOLs may carry forward subject to Section 382 limits in the U.S. No step-up in tax basis. Faster to execute because contracts transfer with the entity.
Asset deal: buyer cherry-picks assets and liabilities and gets a step-up in tax basis equal to fair value, generating future tax shield via depreciation and amortization. More complex — every contract must be re-assigned, and consents may be required. Buyer-friendly tax-wise; seller often resists because of double taxation at the corporate and shareholder levels (in C-corp jurisdictions).
Common M&A interview mistakes
- Quoting accretion without amortization. Forgetting PPA intangible amortization is the single most common error. Always disclose pro forma EPS both pre- and post-amortization.
- Ignoring foregone interest on cash. Cash spent loses interest income. The opportunity cost is real and after-tax.
- Treating revenue synergies and cost synergies the same. Different probability of capture, different timing, different defensibility. Discount revenue synergies harder.
- Confusing equity value and enterprise value in the deal price. Equity value is paid to shareholders. Enterprise value adds assumed debt. Mixing them undercounts the financing burden.
- Forgetting transaction fees. Banker fees, legal fees, financing fees add 1–3% of equity value to the cost. They get capitalized or expensed depending on accounting treatment.
- Pricing 100% of synergies into year one. Cost synergies phase in over 12–24 months. Revenue synergies take longer. Phase them realistically or you overstate accretion.
Worked example: $5B all-cash deal
Acquirer: $20B market cap, 200M diluted shares, $1B standalone net income (EPS = $5.00), 25% tax rate, can issue debt at 6%. Target: $4B equity purchase price + $1B assumed debt = $5B EV, $300M target net income. Deal financed with $4B new debt and $1B existing cash earning 4%.
Pro forma adjustments: new interest = $4B × 6% × (1 − 25%) = $180M after-tax; foregone interest = $1B × 4% × (1 − 25%) = $30M after-tax; intangible amortization (assume $1B intangibles, 10-year life) = $100M × (1 − 25%) = $75M after-tax; cost synergies in year 1 = $50M × (1 − 25%) = $37.5M after-tax.
Pro forma net income = $1,000 + $300 − $180 − $30 − $75 + $37.5 = $1,052.5M. Diluted shares unchanged at 200M (cash deal). Pro forma EPS = $5.26 vs $5.00 standalone → 5.3% accretion in year one. Year two adds full run-rate synergies (~$80M after-tax) and pushes accretion to ~9%.
Run an M&A mock interview today
Get pushed on merger mechanics, financing mix, and synergy defense with structured feedback after every answer.
Frequently asked M&A interview questions
Keep going
Back to the main hub: Investment Banking Interview Questions (2026 Guide)